Last Updated: September 24, 2026

L-glutamine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for l-glutamine and what is the scope of patent protection?

L-glutamine is the generic ingredient in three branded drugs marketed by Emmaus Medcl, Annora Pharma, Novitium Pharma, and Renova Pharms, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

Four suppliers are listed for this compound.

Summary for l-glutamine
US Patents:0
Tradenames:3
Applicants:4
NDAs:5
Finished Product Suppliers / Packagers: 4
Raw Ingredient (Bulk) Api Vendors: 188
Clinical Trials: 196
What excipients (inactive ingredients) are in l-glutamine?l-glutamine excipients list
DailyMed Link:l-glutamine at DailyMed
Recent Clinical Trials for l-glutamine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NYU Langone HealthPHASE2
Synhale TheraputicsPHASE1
Chan, Stephen, MD, PhDPHASE1

See all l-glutamine clinical trials

Pharmacology for l-glutamine
Drug ClassAmino Acid

US Patents and Regulatory Information for l-glutamine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Annora Pharma L-GLUTAMINE l-glutamine FOR SOLUTION;ORAL 219722-001 May 26, 2026 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Renova Pharms L-GLUTAMINE l-glutamine FOR SOLUTION;ORAL 219750-001 May 14, 2026 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novitium Pharma L-GLUTAMINE l-glutamine FOR SOLUTION;ORAL 215647-001 Jul 8, 2024 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Emmaus Medcl NUTRESTORE l-glutamine FOR SOLUTION;ORAL 021667-001 Jun 10, 2004 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Emmaus Medcl ENDARI l-glutamine FOR SOLUTION;ORAL 208587-001 Jul 7, 2017 AA RX Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.